Literature DB >> 21461961

Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation.

Qi Xuan1, Sheng-Li Xu, De-Hong Lu, Shun Yu, Ming Zhou, Kenji Uéda, Ye-Qing Cui, Bo-Yang Zhang, Piu Chan.   

Abstract

Although the increased prevalence of Parkinson's disease (PD) with aging suggests that aging processes predispose dopamine neurons to degeneration, the mechanism involved remains unknown. Dopamine neurons contain significant amounts of neuromelanin, and the amount of neuromelanin increases with aging. In the present study, age-related changes in the number of nigral neurons expressing neuromelanin (NM), α-synuclein, and tyrosine hydroxylase (TH) were stereologically analyzed in the postmortem brains of 28 healthy humans with an age range of 17-84 years. Stereological counting of NM content, α-synuclein content, and TH immunoreactivity revealed significant accumulation of NM and α-synuclein in neurons during the aging process. In cells containing a large amount of NM, α-synuclein-immunoreactive cells in aged individuals outnumbered those of younger individuals. In non-NM cells, the α-synuclein expression profile was similar across age groups. Furthermore, TH-immunoreactive neurons decreased significantly with aging, which was associated with accumulation of NM and α-synuclein. Our results suggest that age related accumulation of NM might induce α-synuclein over-expression and thereby make dopamine neurons more vulnerable to injuries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21461961     DOI: 10.1007/s00702-011-0636-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  34 in total

1.  Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach.

Authors:  C Schmitz; P R Hof
Journal:  J Chem Neuroanat       Date:  2000-10       Impact factor: 3.052

2.  Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.

Authors:  S Yu; X Li; G Liu; J Han; C Zhang; Y Li; S Xu; C Liu; Y Gao; H Yang; K Uéda; P Chan
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

3.  Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Authors:  Glenda M Halliday; Anita Ophof; Melissa Broe; Poul H Jensen; Emma Kettle; Heidi Fedorow; Michael I Cartwright; Francine M Griffiths; Claire E Shepherd; Kay L Double
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

4.  Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture.

Authors:  Wenbo Zhou; Jerome Schaack; W Michael Zawada; Curt R Freed
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

5.  Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons?

Authors:  J Haavik; B Almås; T Flatmark
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

6.  A role for alpha-synuclein in the regulation of dopamine biosynthesis.

Authors:  Ruth G Perez; Jack C Waymire; Eva Lin; Jen J Liu; Fengli Guo; Michael J Zigmond
Journal:  J Neurosci       Date:  2002-04-15       Impact factor: 6.167

Review 7.  Alpha-synuclein aggregation and neurodegenerative diseases.

Authors:  Qiu-Lan Ma; Piu Chan; Mitsunobu Yoshii; Kenji Uéda
Journal:  J Alzheimers Dis       Date:  2003-04       Impact factor: 4.472

8.  Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy.

Authors:  C R Cabello; J J Thune; H Pakkenberg; B Pakkenberg
Journal:  Neuropathol Appl Neurobiol       Date:  2002-08       Impact factor: 8.090

9.  Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.

Authors:  Shun Yu; Xiaohong Zuo; Yaohua Li; Chen Zhang; Ming Zhou; Yu Alex Zhang; Kenji Uéda; Piu Chan
Journal:  Neurosci Lett       Date:  2004-08-26       Impact factor: 3.046

10.  Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells.

Authors:  Dongmei Liu; Ling Jin; Hao Wang; Huanying Zhao; Chunli Zhao; Chunli Duan; Lingling Lu; Bo Wu; Shun Yu; Piu Chan; Yaohua Li; Hui Yang
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

View more
  20 in total

Review 1.  Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2020-01-28       Impact factor: 3.575

Review 2.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 3.  Melanin affinity and its possible role in neurodegeneration.

Authors:  Oskar Karlsson; Nils Gunnar Lindquist
Journal:  J Neural Transm (Vienna)       Date:  2013-07-03       Impact factor: 3.575

Review 4.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 5.  The link between the GBA gene and parkinsonism.

Authors:  Ellen Sidransky; Grisel Lopez
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

6.  The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells.

Authors:  Tianhong Pan; Julie Zhu; Wen-Jen Hwu; Joseph Jankovic
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

7.  Increased α-synuclein phosphorylation and nitration in the aging primate substantia nigra.

Authors:  A L McCormack; S K Mak; D A Di Monte
Journal:  Cell Death Dis       Date:  2012-05-31       Impact factor: 8.469

8.  Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions.

Authors:  Matthias Elstner; Sarina K Müller; Lars Leidolt; Christoph Laub; Lena Krieg; Falk Schlaudraff; Birgit Liss; Chris Morris; Douglass M Turnbull; Eliezer Masliah; Holger Prokisch; Thomas Klopstock; Andreas Bender
Journal:  Mol Brain       Date:  2011-12-21       Impact factor: 4.041

9.  Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.

Authors:  Stefania Romeo; Cristina Viaggi; Daniela Di Camillo; Allison W Willis; Luca Lozzi; Cristina Rocchi; Marta Capannolo; Gabriella Aloisi; Francesca Vaglini; Rita Maccarone; Matteo Caleo; Cristina Missale; Brad A Racette; Giovanni U Corsini; Roberto Maggio
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

Authors:  Minjuan Bian; Jie Liu; Xiaoqi Hong; Mei Yu; Yufang Huang; Zhejin Sheng; Jian Fei; Fang Huang
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.